NCT06181929 A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females
| NCT ID | NCT06181929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sang-Won Um |
| Condition | Health Risk Behaviors |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-06-01 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-arm prospective pilot study in a single institution. The target accrual is 200 participants of Korean, female sex, never smoker status, and family history of lung cancer. The study will aim to enroll 200 participants in two years.
Eligibility Criteria
Inclusion Criteria: 1. Age 45-74 years old 2. Korean female 3. Never smoker defined as a lifetime exposure of less than 100 cigarettes 4. Family history of lung cancer at first degree relatives (parents, siblings, or children) Exclusion Criteria: 1. Prior history of lung cancer. 2. Diagnosis of any cancer within the past five years 3. Participation in a cancer prevention trial. 4. Present symptoms suggestive of current lung cancer, including: unexplained weight loss of over 5 kilograms within the last 12 months or unexplained hemoptysis. 5. Medical or psychiatric condition precluding informed medical consent. 6. History of LDCT screening, chest CT, PET or PET/CT scan within 10 years
Contact & Investigator
Um Sang-Won, PhD
PRINCIPAL INVESTIGATOR
Samsung Medical Center
Frequently Asked Questions
Who can join the NCT06181929 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 74 Years, studying Health Risk Behaviors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06181929 currently recruiting?
Yes, NCT06181929 is actively recruiting participants. Contact the research team at sangwonum72@gmail.com for enrollment information.
Where is the NCT06181929 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06181929 clinical trial?
NCT06181929 is sponsored by Sang-Won Um. The principal investigator is Um Sang-Won, PhD at Samsung Medical Center. The trial plans to enroll 200 participants.